Equity Overview
Price & Market Data
Price: $79.05
Daily Change: $0.00 / 0.00%
Daily Range: $0 - $0
Market Cap: $4,448,996,864
Daily Volume: 0
Performance Metrics
1 Week: -5.53%
1 Month: -5.53%
3 Months: 16.03%
6 Months: -20.95%
1 Year: -22.98%
YTD: -5.53%
Company Details
Employees: 3271
Sector: Health technology
Industry: Medical specialties
Country:
Details
DiaSorin S.p.A. engages in research and development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, North America, and internationally. It provides various immunodiagnostic in the areas, including infectious diseases, endocrinology, gastrointestinal infections, autoimmunity, hypertension, emergency/sepsis, bone metabolism, and oncology under LIAISON XL and LIAISON XS name. The company also offers Simplexa, a congenital CMV direct kit, which detects cytomegalovirus DNA in saliva swab and urine specimens. In addition, it offers LIAISON PLEX Respiratory Flex Assay and the LIAISON PLEX Yeast Blood Culture Assay. Further, the company offers xMAP technology platform, including in vitro diagnostics. The company was founded in 1968 and is headquartered in Saluggia, Italy.